Study
Newsweek Article:
“ALZHEIMER’S DISEASE IS COMPLETELY REVERSED BY REMOVING JUST ONE ENZYME IN NEW STUDY”
apple.news/AVRK5TNVbQ_m5UUAoX4D1Uw
(mice are not humans but exciting nonetheless)
High performance plasma amyloid-B biomarkers test with 90% accuracy detecting Alzheimers see Nature study
A key characteristic of Alzheimer’s is the buildup of a protein called amyloid beta in the brain. This toxic protein can cause dementia. Amyloid has been the overwhelming target of clinical drug trials in the Alzheimer’s field. Bateman estimates the blood test can detect amyloid up to 20 years before a person will develop Alzheimer’s.
The blood tests use mass spectrometry to detect amyloid beta. Dr. Koichi Tanaka, a Nobel Prize-winning chemist, first developed mass spectrometry testing for proteins, and he was instrumental in the Japanese/Australian study.